{"nct_id":"NCT03293498","title":"Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2017-09-18","start_date_type":"ACTUAL","primary_completion_date":"2018-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVAX"]}